20241011_TOWR_Laporan Informasi dan Fakta Material_31735276_lamp3.pdf

This Supplemental Information Disclosure constitutes changes and/or additions to the Disclosure of Information
that was published on September 17, 2024.

This Supplemental Information Disclosure is important to be read and considered by the Company's shareholders
to make a decision regarding the Company's plan to conduct the PMHMETD mentioned above which will be
requested for approval at the Extraordinary General Meeting of Shareholders of the Company which will be held
on October 25, 2024.

If you have any difficulty in understanding the information contained in this Supplemental Information Disclosure
or are in doubt about making decisions, you should consult with a securities broker, investment manager, legal
advisor, public accountant, or other professional advisor.

In accordance with the Company's plan to conduct PMHMETD, the Company intends to seek shareholders' approval
through the Company's Extraordinary General Meeting of Shareholders which will be held on October 25, 2024
(“EGMS”).

All information contained in this Supplemental Information Disclosure is only a proposal, which is subject to the
approval of the EGMS and the Prospectus to be issued in the framework of PMHMETD.


             This Supplemental Information Disclosure is published on October 11, 2024

                                              INTRODUCTION


The Company was established pursuant to Deed of Establishment No. 31, dated June 2, 2008, made
before Dr. Irawan Soerodjo, S.H., MSi., at that time a Notary in Jakarta, which has been approved by
the Minister of Law and Human Rights under Decree No. AHU-37840.AH.01.01.Year 2008, dated July
2, 2008, and announced in the State Gazette of the Republic of Indonesia No. 66, dated August 19,
2014, Supplement No. 44511, and began commercial operations on July 2, 2008.

                                DESCRIPTION OF THE PMHMETD PLAN

A.   MAXIMUM AMOUNT OF FUND RAISING PLAN IN PMHMETD

In this PMHMETD, the Company plans to issue new shares amounting to a maximum amount of
5,000,000,000 (five billion) new shares with an exercise price of Rp900.00 (nine hundred Rupiah)
per share or amounting to Rp4,500,000,000,000.00 (four trillion five hundred billion Rupiah)
(“HMETD”).

The PMHMETD will be carried out with due observance to the applicable laws of Indonesia. The new
shares to be issued in the PMHMETD will be listed on the Indonesia Stock Exchange and will have the
same and equal rights in all respects with all of the Company's previously issued shares.

B.   INDICATIVE PERIOD OF PRE-EMPTIVE RIGHTS

The implementation of the capital increase is carried out through PMHMETD and the submission of
PMHMETD registration statement will be carried out after obtaining the approval of the Company’s
EGMS. In accordance with the provisions of POJK No. 32/2015 and with due observance of other
applicable laws and regulations (if any), the implementation of PMHMETD must be carried out no
later than 12 (twelve) months after the date of EGMS approval.




                                                                                                               2

The implementation of PMHMETD will depend on and be subject to and will be carried out if it has
obtained the approval of the Company's EGMS and obtained an effective statement from OJK on the
PMHMETD registration statement which will be submitted by the Company with reference to the
prevailing laws and regulations in the field of Capital Markets in Indonesia.

C.   INDICATIVE USE OF PROCEEDS

The Company plans to use the funds from the PMHMETD, after deducting the issuance costs, for loan
repayment and for working capital purposes of the Company and/or PT Profesional Telekomunikasi
Indonesia, a 99% owned subsidiary of the Company ("Protelindo"). The loans of the Company
and/or Protelindo that will be repaid will be determined later. The use of proceeds for Protelindo as
mentioned above will be implemented by the Company in accordance with OJK Regulation No.
42/POJK.04/2020 on Affiliated Transactions and Conflict of Interest Transactions.
Final and detailed information regarding the use of funds will be disclosed in the prospectus issued
in connection with the PMHMETD which will be provided to the eligible shareholders in due time, in
accordance with the prevailing laws and regulations in the field of Capital Market in Indonesia.
D.   ANALYSIS OF THE EFFECT OF CAPITAL INCREASE ON THE COMPANY'S FINANCIAL AND
     SHAREHOLDERS’ CONDITION

In connection with the implementation of PMHMETD, the Company will increase authorized capital,
issued capital and fully paid-up capital with the following details:

                         NOMINAL PRICE                                  ESTIMATION AFTER
                                                 BEFORE PMHMETD
                           PER SHARE                                          PMHMETD
 Authorized capital     Rp10.00                Rp1,000,000,000,000.00 Rp2,240,585,000,000.00
                                               or 100,000,000,000      or 224,058,500,000
                                               shares                  shares
 Issued and Paid-up                            Rp510,146,250,000.00    Rp560,146,250,000.00
 Capital                                       or 51,014,625,000       or 56,014,625,000
                                               shares or 51.01% of the shares or 25% of the
                                               Authorized Capital      Authorized Capital


In the event that the Company's shareholders do not exercise their Pre-emptive Rights in the
PMHMETD plan, the Company's shareholders' ownership will be diluted in an amount of a maximum
of 9.12% (without calculating treasury shares) or 8.93% (with calculating treasury shares).


E.    COMPLIANCE WITH APPLICABLE CAPITAL MARKET REGULATIONS

PMHMETD will be implemented in accordance with POJK No. 32/2015. Therefore, the Company must
have obtained the approval of the EGMS which will be held on October 25, 2024 or another date
determined in accordance with applicable regulations. Then the Company will submit a Registration
Statement and supporting documents to OJK and the Registration Statement must have obtained an
effective statement from OJK before the PMHMETD is implemented, provided that the period
between the date of approval of the EGMS until the effectiveness of the Registration Statement is not
more than 12 (twelve) months.



                                                                                                   3

This Supplemental Information Disclosure is carried out to fulfill the provisions of POJK No. 32/2015
and is announced together with the EGMS Announcement through the Indonesia Stock Exchange
website www.idx.co.id, eASY.KSEI which can be accessed through the link https://akses.ksei.co.id
and the Company's website www.ptsmn.co.id.

                   EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS

The Company has announced the plan to hold the EGMS through the Indonesia Stock Exchange’s
website, eASY.KSEI and the Company's website www.ptsmn.co.id on September 17, 2024 and the
invitation to the EGMS will be made on October 2, 2024 in the same media. Meanwhile, the List of
Shareholders containing the names of the Company's shareholders who are entitled to attend the
EGMS is the List of Shareholders of the Company and or securities sub-account holders at the closing
of stock trading on the stock exchange as of October 1, 2024. The EGMS will be held on October 25,
2024.

    If the PMHMETD does not obtain the approval of the EGMS, then the plan can only be
                    resubmitted 12 (twelve) months after the EGMS.

                                   ADDITIONAL INFORMATION

Shareholders who require additional information may contact the Company during business hours
at the address:

                                    Corporate Secretary
                             PT SARANA MENARA NUSANTARA TBK
                                       Branch Office
                                       Menara BCA, 53rd Floor
                                         Jl. M.H. Thamrin No. 1
                                      Jakarta 10310, Indonesia
                                        Tel. (62-21) 2358 5500
                                        Fax. (62-21) 2358 6446
                                     Website: www.ptsmn.co.id
                                Email: investor.relations@ptsmn.co.id




                                                                                                   4